Jun 4, 2025 at 8:05 AM#11
emily_PDX — wow. I've been looking for this exact info for weeks.
3 7paul_denver, TinaHashiRN, robert_kc
Reply Quote Save Share Report
Jun 4, 2025 at 8:22 AM#12
Slightly tangential to MASH prevalence in GLP-1 but tampaLisa73 reminded me — has anyone else noticed changes in their alcohol tolerance?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
19 1mike.trainer_LA, sarah_nash92, FitDadDave and 16 others
Reply Quote Save Share Report
Jun 4, 2025 at 8:39 AM#13
Thanks for sharing this, tampaLisa73. A few questions about your MASH prevalence in experience:
- What dose did you start at?
- How long before you noticed side effects improving?
- Did your provider have any specific recommendations about MASH prevalence?
I am in a similar boat and trying to learn from others' experiences before my next appointment.
15 7NicoleRaleigh, james_edin, FranDenver and 12 others
Reply Quote Save Share Report
Jun 4, 2025 at 8:56 AM#14
OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on MASH prevalence in GLP-1.
To answer bri_stats: I get my labs done through Quest every 3 months.
Quick update: my latest labs came back even better. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Last edited: Jun 4, 2025 at 9:56 AM
46 10mike.trainer_LA, sarah_nash92, FitDadDave and 43 others
Reply Quote Save Share Report
Jun 4, 2025 at 9:13 AM#15
Relevant to MASH prevalence in GLP-1 users — here is my latest bloodwork comparison:
Key improvements: A1C 8.0% → 5.3%, triglycerides 199 → 99 mg/dL, hsCRP 6.0 → 1.1 mg/L. All on tirzepatide for 15 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
47 16mike_nyc, VendorMark, COA_Karl and 44 others
Reply Quote Save Share Report